Induced cross-resistance of BRAFV600E melanoma cells to standard chemotherapeutic dacarbazine after chronic PLX4032 treatment
Author:
Publisher
Springer Science and Business Media LLC
Subject
Multidisciplinary
Link
http://www.nature.com/articles/s41598-018-37188-0.pdf
Reference48 articles.
1. Winder, M. & Viros, A. Mechanisms of Drug Resistance in Melanoma. Handb Exp Pharmacol, https://doi.org/10.1007/164_2017_17 (2017).
2. Atkins, M. B. et al. Phase III trial comparing concurrent biochemotherapy with cisplatin, vinblastine, dacarbazine, interleukin-2, and interferon alfa-2b with cisplatin, vinblastine, and dacarbazine alone in patients with metastatic malignant melanoma (E3695): a trial coordinated by the Eastern Cooperative Oncology Group. J Clin Oncol 26, 5748–5754, https://doi.org/10.1200/JCO.2008.17.5448 (2008).
3. Garbe, C., Eigentler, T. K., Keilholz, U., Hauschild, A. & Kirkwood, J. M. Systematic review of medical treatment in melanoma: current status and future prospects. Oncologist 16, 5–24, https://doi.org/10.1634/theoncologist.2010-0190 (2011).
4. Plummer, R. et al. A phase II study of the potent PARP inhibitor, Rucaparib (PF-01367338, AG014699), with temozolomide in patients with metastatic melanoma demonstrating evidence of chemopotentiation. Cancer Chemother Pharmacol 71, 1191–1199, https://doi.org/10.1007/s00280-013-2113-1 (2013).
5. Tawbi, H. A. et al. Inhibition of DNA repair with MGMT pseudosubstrates: phase I study of lomeguatrib in combination with dacarbazine in patients with advanced melanoma and other solid tumours. Br J Cancer 105, 773–777, https://doi.org/10.1038/bjc.2011.285 (2011).
Cited by 23 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Patient-derived melanoma models;Pathology - Research and Practice;2024-07
2. Blick ins Innere: Analyse von 3D-Kulturen mittels Mikrokavitätenarrays;BIOspektrum;2024-06
3. Role of Annexin 7 (ANXA7) as a tumor suppressor and a regulator of drug resistance in thyroid cancer;2024-05-20
4. Microcavity well-plate for automated parallel bioelectronic analysis of 3D cell cultures;Biosensors and Bioelectronics;2024-04
5. Clonal differences underlie variable responses to sequential and prolonged treatment;Cell Systems;2024-03
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3